Asia Pacific Medical Group
A China-focused hospital operator
About Asia Pacific Medical Group
Established in 1992, Asia Pacific Medical Group (APMG) operates as a for-profit specialty hospital group primarily focused on the Chinese market. The company was founded by Dr. Michael Choy along with a group of 35 US-based physicians and surgeons who aimed to introduce high-standard medical services to the population of China. APMG has positioned itself as a significant private healthcare provider in the region, addressing the growing demand for quality medical care, particularly in underserved specialty areas.
The group's core business revolves around operating a network of hospitals and clinics, with a strategic emphasis on neurology, neurosurgery, and oncology. A notable achievement in its history was introducing the first Gamma Knife machine to China, a technology used for treating brain tumors with focused radiation. This underscores the group's commitment to leveraging advanced medical technology. The company serves both local and international patients across its facilities in major Chinese cities and other parts of Southeast Asia. Its business model focuses on providing quicker and more affordable access to professional treatment compared to the often-overburdened public medical system.
APMG's service portfolio encompasses a range of primary care and specialized treatments, including neurology, oncology, cardiovascular services, pediatrics, and dermatology. The company's revenue is generated through the provision of these healthcare services at its chain of hospitals and clinics. In 2016, the private equity firm Bain Capital acquired a large majority stake in APMG, signaling a significant milestone and providing capital for further expansion, particularly in China's tier-one cities. As of early 2025, reports indicated that Bain Capital was considering an exit, with APMG's revenue for the 12 months ending September 2024 at approximately USD 220 million. The group operates nine core member hospitals with a total of nearly 3,500 beds, handling almost two million outpatient visits annually.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 2.4/100
- Industry
- Health
- Sector
- Hard Tech
- Business model
- Marketplace & ecommerce
- Client focus
- B2C
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Nov 2022 | $28M | $110M | IDG Capital · GL Capital · PICC Capital Equity Investment | ↗ |
Growth signals
Latest recorded traffic for Asia Pacific Medical Group is 610 monthly website visits, up 69.4% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Asia Pacific Medical Group in its local ecosystem
The Asia Pacific Medical Group office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
IDG Capital- GCGL Capital
- PIPICC Capital Equity Investment
Other known investors2 additional known investors
Bain Capital- BEBain Capital Private Equity
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Asia Pacific Medical Group on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Asia Pacific Medical Group’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









